TY  - GEN
AU  - Motzer,R J
AU  - Murphy,B A
AU  - Bacik,J
AU  - Schwartz,L H
AU  - Nanus,D M
AU  - Mariani,T
AU  - Loehrer,P
AU  - Wilding,G
AU  - Fairclough,D L
AU  - Cella,D
AU  - Mazumdar,M
TI  - Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma
SN  - 0732-183X
PY  - 2000///0914
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - administration & dosage
KW  - Isotretinoin
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Models, Statistical
KW  - Multivariate Analysis
KW  - Quality of Life
KW  - Recombinant Proteins
KW  - Statistics, Nonparametric
KW  - Surveys and Questionnaires
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.2000.18.16.2972
ER  -